SLCTR/2014/028尚未招募未知
Randomized, double blind, controlled study on efficacy and safety of intralesional metronidazole vs intralesional sodium stibogluconate in L. donovani cutaneous leishmaniasis
Base Hospital Hambanthota0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.>12 years of age
- •2.Positive slit skin smear and /or skin biopsy for leishmania parasites
排除标准
- •1.Pregnancy
- •2.Breast feeding
- •3.Known renal impairment
- •4.Known liver impairment
- •5.Congestive cardiac failure
研究者
相似试验
尚未招募
不适用
Efficacy and overall impact on wound healing of acetic acid and ascorbic acid as antiseptics in chronic diabetic woundsChronic diabetic woundsSLCTR/2014/035Department of Surgery
招募中
3 期
Study on the efficacy of Probiotics in the treatment of Asthma in children and adolescentsAsthmaRBR-7jsgnshHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
已完成
不适用
A randomized, double-blind and controlled study of clearing heat and resolving depression in the treatment of bipolar depression and fire heat depressioBipolar disorderITMCTR2200005825Beijing Anding Hospital, Capital Medical University
进行中（未招募）
1 期
A controlled, double-blind and randomized study, to compare the immunogenicity and safety of HEXAVAC manufactured by an upgraded process to HEXAVAC manufactured by the current process when given to healthy infants at 2, 4 & 6 months of age followed by a booster dose at 12 months of ageThe vaccine is indicated for primary and booster vaccination of children against six infectious diseases: diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis caused by 3 types of poliovirus (type 1,2 and 3), and invasive infections caused by Haemophilus influenza type b.EUCTR2005-002578-31-CZSanofi Pasteur MSD S.N.C.800
进行中（未招募）
1 期
A controlled, double-blind and randomized study, to compare the immunogenicity and safety of HEXAVAC manufactured by an upgraded process to HEXAVAC manufactured by the current process when given to healthy infants at 2, 4 & 6 months of age followed by a booster dose at 12 months of ageThe vaccine is indicated for primary and booster vaccination of children against six infectious diseases: diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis caused by 3 types of poliovirus (type 1,2 and 3), and invasive infections caused by Haemophilus influenza type b.EUCTR2005-002578-31-SKSanofi Pasteur MSD S.N.C.800